The Venture Codex Logo

The Venture Codex

Overview

Non-profit academic medical center providing exceptional patient care.

Deals · 12mo

0

Stage focus

—

Geographic focus

United Kingdom

Sector focus

Communities
Health Care
Medical
Non Profit

Investment portfolio

1rounds
NAMEDATESIZE
52 North Health
Dec 2024Led
$6 MOther Equity
52 North Health
Dec 2024Led
$6 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cedars-Sinai Intellectual Property: 1 funding rounds are recorded in the selected participation categories.All available history.
Cedars-Sinai Intellectual Property: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity10

Monthly Deal Activity

Cedars-Sinai Intellectual Property: 1 deals are recorded across 23 months.All available history.
Cedars-Sinai Intellectual Property: 1 deals are recorded across 23 months. All available history
MonthDeals
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cedars-Sinai Intellectual Property: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cedars-Sinai Intellectual Property: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1
AI & Machine Learning1

Deal Size Distribution

Cedars-Sinai Intellectual Property: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cedars-Sinai Intellectual Property: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cedars-Sinai Intellectual Property: Europe has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Cedars-Sinai Intellectual Property: Europe has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Europe1
Cedars-Sinai Intellectual Property: 5 co-investors are shown, with Cambridge Enterprise sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cedars-Sinai Intellectual Property: 5 co-investors are shown, with Cambridge Enterprise sharing 1 recorded deals. All available history
Co-investorShared deals
Cambridge Enterprise1
Cancer Research Horizons1
Macmillan Cancer Support1
Meridian Health Ventures (KHP Ventures)1
OKG Capital1

Investment Strategy

Cedars-Sinai Intellectual Property: Led accounts for 100% and participating for 0% of round participation.All available history.
Cedars-Sinai Intellectual Property: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Cedars-Sinai Intellectual Property: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Cedars-Sinai Intellectual Property: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Anne Wellington

Managing Director, Cedars-Sinai Accelerator

Arthur Ochoa

SVP, Advancement & CAO

David Wrigley

CFO & Senior Vice President Finance

Michael Langberg

Senior Vice President of Medical Affairs & Chief Medical Officer

Raj Khandwalla

Assistant Professor of Medicine

Thomas Priselac

CEO & President

Timothy Henry, MD

Chief of Cardiology

Willis Tang

Research Assistant - Orthopedic Trauma